|Publication number||US4069819 A|
|Application number||US 05/711,962|
|Publication date||Jan 24, 1978|
|Filing date||Aug 5, 1976|
|Priority date||Apr 13, 1973|
|Publication number||05711962, 711962, US 4069819 A, US 4069819A, US-A-4069819, US4069819 A, US4069819A|
|Inventors||Luigi Valentini, Michele Maiorano|
|Original Assignee||Societa Farmaceutici S.P.A.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (4), Referenced by (143), Classifications (10) |
|External Links: USPTO, USPTO Assignment, Espacenet|
US 4069819 A
An inhalation device of cylindrical form is disclosed for the administration of medicaments in finely divided form, having a nebulization chamber for a capsule with the medicament and in which an air passageway is formed in such manner as to set the flowing air in vortical motion. The vortical motion is obtained by means of holes suitably directed or by other means such as inclined surfaces, helicoidal parts or the like. The nebulization chamber is such as to cause the capsule, under the action of the flowing air, to make movements of rotation, precession and vibration about and along its longitudinal axis within the nebulization chamber. A series of air inlet holes may be provided in the periphery of the lower portion of the nebulization chamber, the axes of which are offset from the central axis of the nebulization chamber. One or more push button-actuated needles pierce the capsule and release the powdered medicament.
What is claimed is:
1. A pen-shaped pocket-size inhalation device of relative slight bulk and of elongated generally cylindrical form for the administration upon inhalation via a persons' nose or mouth of a medicament in finely-divided form contained within a capsule disposed in the interior of the device, said device including a generally cylindrical wall structure having a centrally unobstructed axially-extending nebulization chamber adapted to contain said capsule, said nebulization chamber having dimensions slightly larger than, and adapted to loosely hold, a capsule of smaller dimensions containing mediament therein in substantially axial position with respect to said nebulization chamber said device having air passage means extending through said wall structure adjacent one end of said nebulization chamber for the flow of air through said wall structure and into said nebulization chamber for setting in vortical motion air flowing through the device solely by inhalation, thereby causing the loosely held capsule disposed within the slightly larger nebulization chamber, under the action of the flowing air, to make random movements of rotation, precession and vibration about and along its longitudinal axis while loosely held and freely movable within the nebulization chamber, unitary spring-biased means including at least one capsule-perforating needle disposed at one end of said cylindrical structure and in an axially retracted manner with respect to said cylindrical structure, said needle disposed adjacent one end of the nebulization chamber and including means actuatable manually by the person whereby the end of the capsule may be readily perforated for release of the contained medicament into the air flowing with a vortical motion through the nebulization chamber and at least one discharge hole in said cylindrical structure communicating with the nebulization chamber at the opposite end thereof for releasing finely-divided medicament dispersed in the air from the nebulization chamber into the person's nose or mouth.
2. An inhalation device according to claim 1, wherein the vortical motion of the air is obtained by means of a plurality of openings in the wall of the nebulization chamber.
3. An inhalation device according to claim 2, wherein the side wall of the nebulization chamber is provided with a plurality of air inlet openings located about the periphery thereof, the axes of the openings in the plane perpendicular to the central axis of the nebulization chamber being offset from said central axis, thereby bringing about the said vortical flow of air through said nebulization chamber.
4. An inhalation device according to claim 1, including a spring-loaded pushbutton located in the end thereof opposite the nebulization chamber, and slidably disposed in said device so that upon pressing said pushbutton, one or more needles fixedly associated with the pushbutton are moved against and into the finely-divided medicament-containing capsule disposed within the nebulization chamber, causing perforation of the capsule and from the holes thus obtained, releasing from the capsule the finely-divided medicament which is then dispersed in the vortically flowing air by which the finely-divided medicament is introduced into the person's nose or mouth.
5. An inhalation device according to claim 1, including a cap for same provided with a chamber having a cavity adapted to contain spare finely-divided medicament-containing capsules.
This is a Continuation of application Ser. No. 576,204 filed May 9, 1975 now abandoned, which in turn is a continuation of application Ser. No. 414,214, filed Nov. 9, 1973 and now abandoned.
The present invention relates to a device for the administration of medicaments in finely divided form, by oral inhalation.
Many devices for the administration of medicaments in finely divided form have been previously described (e.g., British Pat. No. 1,182,779; U.S. Pat. No. 3,635,219). Each, however, is limited with regard to the movement of the capsule of the device in its housing under the action of air. In particular, in the prior art devices the ejection of the powder from the capsule depends almost exclusively on its rotatory motion around its axis and this involves the disadvantage of an irregularity of ejection in time space.
It is an object of the present invention to overcome the above and other disadvantages. For the purpose, the capsule of the device is so constructed and arranged that it is subject to three movements: rotation, precession and vibration. This allows a regular and complete nebulization of the powdered medicament.
More particularly, the present invention comprises an inhalation device of cylindrical form, having at one end a nebulization chamber inside of which is placed the capsule containing the powdered medicament. The passageway for the air is made in such manner as to set the air itself in vortical motion. This may be achieved either by means of holes or passageways suitably oriented, or by means of other elements such as inclined surfaces, helicoidal parts or the like.
The nebulization chamber is of course larger in cross-section than the capsule and has such a form that the entrance of air thereto during inspiration, with a vortical movement, imparts the aforesaid movements of rotation, precession and vibration to the capsule which is loosely held within the nebulization chamber. These movements bring about the regular and total release of the powdered medicament. The quantitative relationship of these three movements is determined by the shape of the chamber.
At the other end of the inhalation device a pushbutton is provided which upon pressing causes one or more needles, generally three, to press against the capsule, causing perforation of the capsule. The powdered medicament comes out of these holes and then is dispersed in the air.
The end of the inhalation device which is adapted for inspiration is protected by a cap provided with a clip, and within which there is a cavity for holding a number (e.g., three) spare capsules. The capsules containing the powdered medicament are made of a material readily perforable by the needles, gelatine being a preferred example of such a material.
The inhalation device is simple to use and is of relatively slight bulk and therefore one of minimum encumbrance. It can be carried in the pocket as a pen, which it resembles, and the cap prevents external contamination. In use, one merely takes off the cap, brings the device to the nose or mouth, presses the push-button, and inspires.
In order still further to explain the device as regards its form and its way of working, reference is made to the accompanying drawings, wherein:
FIG. 1 represents the whole inhalation device in a static position.
FIG. 2 is a section through the upper end of the device in FIG. 1 with the cap removed.
FIG. 3 is a section through a lower end of the device in FIG. 1.
FIG. 4 is a section through a cap at the upper end of the device in FIG. 1.
FIG. 5 shows on a larger scale a nebulization chamber in FIG. 2, and
FIG. 6 is a section on VI -- VI of FIG. 5.
With reference to the drawings, an inhalation device comprises a nebulization chamber B (FIGS. 2 and 5) shown as containing a capsule C of finely divided medicament. The chamber B is provided with a number of passageways H for the admission of air. The chamber B and passageways H are so arranged, as to the internal shape of the chamber B in relation to the capsule C and the orientation, direction and dimensions of the passageways H, that on inhalation air drawn in through the passageways H is put in a vortical motion, thus subjecting the capsule C to rotary, precessional and vibratory motion.
The inhalation device has at the upper end an inspiration opening A (FIGS. 2 and 5) which is applied to the nose or mouth for inhalation. For carrying purposes, the inhalation device is provided with a cap J (FIGS. 1 and 4) screw-threaded over the inspiration opening A. The cap J is provided with a pocket clip F and a cavity for up to three spare capsules G.
At the lower end is a push-button E (FIGS. 1 and 3) for driving three needles D into the capsule C to liberate medicament. The push-button E is integral with a shaft S from the top of which project the needles D. Near the top of the shaft S, a short relatively narrow slot T is provided that extends all the way through the shaft.
A lower generally hollow cylindrical part L of the inhalation device is pierced by two holes into which a peg R is inserted in tight press-fit engagement. The peg R is of such a length that its ends are flush with the outer circumference of that portion of the outer diameter of the hollow cylindrical part into which it fits, and the diameter of the peg R is slightly less than the thickness of the slot T so that it can slide freely up and down within the slot.
The needles D extend into, and can be pushed upwardly through, matching holes provided near the upper end of the lower part L. The lower part L surrounds the upper part of the shaft S with sufficient clearance between the two so as to permit free movement between the two in an axial direction; a movement the maximum extent of which is predetermined by the length of the slot T.
The push-button E is loaded by a coil spring K bearing on the lower part L of the inhalation device for the withdrawal of the needles D after perforation of the capsule C. The lower part L fits inside the lower end of the upper part of the device shown in FIG. 2, and is secured therein by a cover M, which engages the upper part through screw threads N, and by a coil spring P which bears on the lower end of the upper part of the device and on a shoulder Q on the lower end of the lower part L.
Upon actuation by pressure of the finger of the user on push-button E, both the shaft S and the lower part L are first pushed upwardly until the upper part of L engages the capsule C in the chamber B. Further pressure on push button E causes the shaft S carrying the needles D to continue upwardly to the extent permitted by the slot T while L remains stationary. This causes the needles D to perforate the capsule C. On releasing the push-button E, the withdrawal spring K returns the push-button E and associated parts to the carrying position and thus removes the needles D from the capsule C. The inhalation device can then be used by placing the inspiration opening A in the nose or mouth and inspiring.
Air is thus drawn in through the passageways H, and given a vortical movement thereby. The capsule C is thus subjected to a rotary, precessional and vibratory movement, and the medicament contained in the capsule is thus used up regularly, and eventually completely.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3635219 *||Jun 4, 1969||Jan 18, 1972||Fisons Pharmaceuticals Ltd||Inhalation device|
|US3795244 *||Feb 2, 1973||Mar 5, 1974||Syntex Corp||Inhalation device|
|US3807400 *||Jun 26, 1972||Apr 30, 1974||Isf Spa||Inhaling device for medicinal powder compositions|
|US3906950 *||Apr 2, 1974||Sep 23, 1975||Isf Spa||Inhaling device for powdered medicaments|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4860740 *||Feb 10, 1987||Aug 29, 1989||Riker Laboratories, Inc.||Powder inhalation device|
|US4889114 *||Jul 2, 1987||Dec 26, 1989||Boehringer Ingelheim Kg||Powdered pharmaceutical inhaler|
|US4995385 *||Feb 23, 1990||Feb 26, 1991||Phidea S.P.A.||Inhaler with regular complete emptying of the capsule|
|US5070870 *||Feb 22, 1989||Dec 10, 1991||Pearce John O||Dispensers for powdered medication|
|US5152284 *||May 24, 1991||Oct 6, 1992||Phidea S.P.A.||For administering medication|
|US5161524 *||Aug 2, 1991||Nov 10, 1992||Glaxo Inc.||Dosage inhalator with air flow velocity regulating means|
|US5351683 *||Feb 1, 1993||Oct 4, 1994||Chiesi Farmaceutici S.P.A.||Device for the administration of powdered medicinal substances|
|US5388572 *||Oct 26, 1993||Feb 14, 1995||Tenax Corporation (A Connecticut Corp.)||Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same|
|US5388573 *||Dec 2, 1993||Feb 14, 1995||Tenax Corporation||Dry powder inhalator medicament carrier|
|US5460173 *||Mar 25, 1994||Oct 24, 1995||Tenax Corporation||Dry powder inhaler medicament carrier|
|US5505194 *||Oct 4, 1994||Apr 9, 1996||Abbott Laboratories||Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions|
|US5542411 *||Jun 28, 1994||Aug 6, 1996||Novo Nordisk A/S||Manually operated dispenser for dispensing a predetermined amount of powdered substance|
|US5687710 *||Jun 1, 1995||Nov 18, 1997||Schering Corporation||Inhaler for powdered medications having spiral deagglomeration chamber|
|US5740792 *||Jun 1, 1995||Apr 21, 1998||Schering Corporation||Inhaler for powdered medications with gear-teeth counter assembly|
|US5740794 *||Jun 7, 1995||Apr 21, 1998||Inhale Therapeutic Systems||Apparatus and methods for dispersing dry powder medicaments|
|US5752505 *||Mar 18, 1997||May 19, 1998||Unisia Jecs Corporation||Inhalation-type medicine delivery device|
|US5780014 *||Mar 13, 1996||Jul 14, 1998||Inhale Therapeutic Systems||Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin|
|US5785049 *||Sep 21, 1994||Jul 28, 1998||Inhale Therapeutic Systems||Method and apparatus for dispersion of dry powder medicaments|
|US5787881 *||Feb 3, 1997||Aug 4, 1998||Fisons Plc||Inhalation device|
|US5797391 *||Sep 28, 1993||Aug 25, 1998||Rhone-Poulenc Rorer Limited||Inhaler|
|US5829434 *||Dec 16, 1993||Nov 3, 1998||Schering Corporation||Inhaler for powdered medications|
|US5993783 *||Jul 13, 1998||Nov 30, 1999||Inhale Therapeutic Systems||Aerosols|
|US5997848 *||Mar 21, 1997||Dec 7, 1999||Inhale Therapeutic Systems||Methods and compositions for pulmonary delivery of insulin|
|US6051256 *||May 8, 1996||Apr 18, 2000||Inhale Therapeutic Systems||Dispersible macromolecule compositions and methods for their preparation and use|
|US6062213 *||Jun 16, 1998||May 16, 2000||Fuisz Technologies Ltd.||Single unit dose inhalation therapy device|
|US6089228 *||Jan 8, 1998||Jul 18, 2000||Inhale Therapeutic Systems||Apparatus and methods for dispersing dry powder medicaments|
|US6230707 *||Jul 25, 1994||May 15, 2001||Hoerlin Ernst||Powder inhaler|
|US6257233||May 14, 1999||Jul 10, 2001||Inhale Therapeutic Systems||Dry powder dispersing apparatus and methods for their use|
|US6308704 *||Aug 4, 1997||Oct 30, 2001||Astra Aktiebolag||Process and apparatus for mixing cohesive powders|
|US6325061||Mar 30, 1999||Dec 4, 2001||Astra Aktiebolag||Inhalation device|
|US6423344||Feb 4, 2000||Jul 23, 2002||Inhale Therapeutic Systems||Dispersion of dry powders, atomizing, drying and accumulation of particles|
|US6470884||Apr 16, 2001||Oct 29, 2002||Aventis Pharma Limited||Capsule opening arrangement for use in a powder inhaler|
|US6509006||Oct 26, 1999||Jan 21, 2003||Inhale Therapeutic Systems, Inc.||Readily and reliably dispersible dry powder biocompatible particles of alpha-1-antitrypsin|
|US6543448||May 30, 2000||Apr 8, 2003||Inhale Therapeutic Systems, Inc.||Apparatus and methods for dispersing dry powder medicaments|
|US6546929||Jun 4, 2001||Apr 15, 2003||Inhale Therapeutic Systems, Inc.||Dry powder dispersing apparatus and methods for their use|
|US6582728||Apr 14, 1995||Jun 24, 2003||Inhale Therapeutic Systems, Inc.||On carrier of human serum albumin, carbohydrate, amino acid, polypeptide, buffer and/or salts; drug delivery to lungs|
|US6586008||Aug 25, 1999||Jul 1, 2003||Advanced Inhalation Research, Inc.||For delivery to the pulmonary system; particles consist of a therapeutic, prophylactic or diagnostic agent, or any combination thereof, an amino acid or salt thereof, and a phospholipid or combination of phospholipids|
|US6592904||Nov 9, 2001||Jul 15, 2003||Inhale Therapeutic Systems, Inc.||Atomizing liquid solutions of the macromolecules, drying the droplets, and collecting the particles; process control; especially for proteins, a nucleic acids, and a high molecular weight polysaccharides.|
|US6679255 *||Feb 28, 2002||Jan 20, 2004||Ivo E. Pera||Inhaling device for dispensing powdered medicaments contained in a capsule through the respiratory tract|
|US6679256||Dec 6, 2000||Jan 20, 2004||Nektar Therapeutics||Systems and methods for extracting powders from receptacles|
|US6681767||May 1, 2000||Jan 27, 2004||Nektar Therapeutics||Method and device for delivering aerosolized medicaments|
|US6685967||Jun 17, 1996||Feb 3, 2004||Nektar Therapeutics||Spray dried powder|
|US6705313||May 9, 2002||Mar 16, 2004||Ph&T S.P.A.||Device usable in the treatment of affections of the airways|
|US6732732||Oct 10, 2002||May 11, 2004||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US6737045||May 7, 2002||May 18, 2004||Nektar Therapeutics||Methods and compositions for the pulmonary delivery insulin|
|US6749835||Aug 23, 2000||Jun 15, 2004||Advanced Inhalation Research, Inc.||Hydroxy-di- or tricarboxylic acid, phospholipid, inorganic salt and active ingredient; nonagglomerating; avoiding or suspending lung's natural clearance mechanisms until drug delivery is complete; short and long term release|
|US6772755||Feb 28, 2002||Aug 10, 2004||Ivo E. Pera||Pen-shaped inhaling device for dispersing powdered medicaments through the respiratory tract|
|US6797258||Feb 8, 2002||Sep 28, 2004||Nektar Therapeutics||Compositions and methods for the pulmonary delivery of aerosolized macromolecules|
|US6858199||Jun 9, 2000||Feb 22, 2005||Advanced Inhalation Research, Inc.||High efficient delivery of a large therapeutic mass aerosol|
|US6881200 *||Feb 10, 1999||Apr 19, 2005||Powderject Research Limited||Needleless syringe using super sonic gas flow for particle delivery|
|US6901929||Dec 19, 2002||Jun 7, 2005||Nektar Therapeutics||Aerosolization; comprises pressurization cylinders; drug delivery|
|US6921527||Jan 31, 2003||Jul 26, 2005||Nektar Therapeutics||Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery|
|US6921528||Oct 8, 2003||Jul 26, 2005||Advanced Inhalation Research, Inc.||Highly efficient delivery of a large therapeutic mass aerosol|
|US6932082||Feb 20, 2003||Aug 23, 2005||3M Innovative Properties Company||Spacer or actuator for inertial removal of the non-respirable fraction of medicinal aerosols|
|US6948496||Jul 20, 2001||Sep 27, 2005||Vectura, Limited||for the delivery of a medicament to the lung, more particularly a medicament in powder form|
|US7032593||Apr 17, 2002||Apr 25, 2006||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US7097827||Sep 13, 2002||Aug 29, 2006||Inhale Therapeutic Systems, Inc.||Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments|
|US7138141||Mar 31, 2003||Nov 21, 2006||Nektar Therapeutics||Atomizing proteins, nucleic acids, or polysaccharides to form microstructure drops used as inhalants; drug delivery|
|US7146978||Feb 5, 2004||Dec 12, 2006||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US7252840||Aug 23, 2000||Aug 7, 2007||Advanced Inhalation Research, Inc.||Administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent, or any combination thereof, and a hydrophobic amino acid or salt thereof|
|US7278419||Jan 30, 2004||Oct 9, 2007||Novo Nordisk A/S||Method for treating diabetes mellitus in a patient|
|US7278425||Feb 5, 2004||Oct 9, 2007||Alkermes, Inc.||Inhalation device and method|
|US7284553 *||Dec 4, 2003||Oct 23, 2007||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient|
|US7326691||Jun 21, 2005||Feb 5, 2008||Nektar Therapeutics||Pulmonary and/or nasal fungal infection|
|US7422013||Mar 9, 2005||Sep 9, 2008||Nektar Therapeutics||Dry powder dispersing apparatus and methods for their use|
|US7448375||May 17, 2005||Nov 11, 2008||Aradigm Corporation||Method of treating diabetes mellitus in a patient|
|US7521069||Jul 1, 2003||Apr 21, 2009||Novartis Ag||Methods and compositions for pulmonary delivery of insulin|
|US7556798||Jun 8, 2001||Jul 7, 2009||Alkermes, Inc.||Single, breath-activated step of delivering a drug to the pulmonary system by inhaling dry powder particles as carriers for adhered, adsorbed or chemically-combined bioactive agents; 50% of stored particle mass delivered; 5 milligrams of drug delivered; antiagglomerants; asthma; cyctic fibrosis|
|US7559325 *||Apr 9, 2004||Jul 14, 2009||Novartis Pharma Ag||Aerosolization apparatus with air inlet shield|
|US7618394||Dec 9, 2002||Nov 17, 2009||Powderject Research Limited||Needleless syringe using supersonic gas flow for particle delivery|
|US7669596 *||Dec 5, 2003||Mar 2, 2010||Novartis Pharma Ag||Aerosolization apparatus with rotating capsule|
|US7678364||Mar 30, 2001||Mar 16, 2010||Alkermes, Inc.||Dry powder; complex|
|US7744925||May 20, 2005||Jun 29, 2010||Quadrant Drug Delivery Limited||Insulin and a sugar alcohol; powder for pulmonary delivery; inhalants; storage stability|
|US7780991||May 20, 2005||Aug 24, 2010||Quadrant Drug Delivery Limited||for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, delivery vehicle being sized and shaped for penetrating the epidermis; vehicle further comprises a stabilizing polyol glass, in particular, trehalose|
|US7785631||May 20, 2005||Aug 31, 2010||Quadrant Drug Delivery Limited||Solid dose delivery vehicle and methods of making same|
|US7802570 *||Dec 27, 2007||Sep 28, 2010||Breathe Pharmaceuticals||Drug transfer device|
|US7807200||Oct 4, 2007||Oct 5, 2010||Alkermes, Inc.||Producing nonagglomerating materials for inhalation delivery; flowability, aerosolization; utilizing carboxylic acid or salt, phospholipid, multivalent salt and solvent|
|US7870856||Apr 10, 2007||Jan 18, 2011||Boehringer Ingelheim International Gmbh||Inhaler|
|US7942846||Aug 31, 2007||May 17, 2011||Powderject Research Limited||Needleless syringe using supersonic gas flow for particle delivery|
|US7954491||Jun 14, 2004||Jun 7, 2011||Civitas Therapeutics, Inc.||Low dose pharmaceutical powders for inhalations|
|US8006695||Nov 10, 2005||Aug 30, 2011||Cipla Limited||Inhaler|
|US8161969||Mar 21, 2008||Apr 24, 2012||Novartis Ag||Dry powder dispersing apparatus and methods for their use|
|US8173168||Sep 28, 2006||May 8, 2012||Novartis Pharma Ag||Dispersible macromolecule compositions and methods for their preparation and use|
|US8273330||Apr 24, 2003||Sep 25, 2012||Nektar Therapeutics||Particulate materials|
|US8298575||Jan 8, 2008||Oct 30, 2012||Boehringer Ingelheim Pharma Gmbh & Co. Kg||consist of water-insoluble hydrophobic synthetic materials which do not significantly affect the pharmaceutical quality of the contents themselves, but improve usability of filled capsules with regard to function, longevity, and/or the geographic location of their use|
|US8337895||Jul 29, 2009||Dec 25, 2012||Novartis Ag||Spray drying process control of drying kinetics|
|US8397717||Oct 20, 2006||Mar 19, 2013||Boehringer Ingelheim International Gmbh||Inhaler with mouthpiece having a microbiological protective function|
|US8404217||Jul 22, 2005||Mar 26, 2013||Novartis Ag||antifungal administered via inhalation; good dispersibility and storage stability; efficiently delivered to the deep lung; treating pulmonary aspergillosis with amphotericin B-containing formulations|
|US8496002||Jun 10, 2008||Jul 30, 2013||Civitas Therapeutics, Inc.||Powder inhaler devices|
|US8513204||Sep 20, 2006||Aug 20, 2013||Novartis Ag||Compositions comprising amphotericin B, mehods and systems|
|US8522775 *||Jun 15, 2007||Sep 3, 2013||Cipla Limited||Dry powder inhaler|
|US8573197||Oct 25, 2007||Nov 5, 2013||Novartis Ag||Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices|
|US8609630||Feb 5, 2013||Dec 17, 2013||Bebaas, Inc.||Vitamin B12 compositions|
|US8662076||Jan 6, 2006||Mar 4, 2014||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Two-part capsule with pre-closure for housing pharmaceutical preparations for powder inhalers|
|US8664187||Feb 24, 2012||Mar 4, 2014||Novartis Ag||Methods of treatment of endobronchial infections|
|US8715623||Oct 31, 2007||May 6, 2014||Novartis Ag||Pulmonary delivery of aminoglycoside|
|US20090320838 *||Jun 15, 2007||Dec 31, 2009||Cipla Limited||Dry powder inhaler|
|US20110277752 *||Dec 4, 2008||Nov 17, 2011||Novartis Ag||Receptacle for an aerosolizable pharmaceutical formulation|
|DE102007033860A1||Jul 20, 2007||Jan 22, 2009||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Test arrangement for testing sealing between mouthpiece of inhaler and user's lips has channel for secondary air around user's lips with second flow measurement device|
|DE102007036412A1||Aug 2, 2007||Feb 19, 2009||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Prüfvorrichtung|
|DE102007052871A1||Nov 2, 2007||May 7, 2009||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen|
|DE202008015493U1||Nov 21, 2008||Feb 12, 2009||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Faltschachtel|
|EP0147755A2 *||Dec 15, 1984||Jul 10, 1985||Boehringer Ingelheim Kg||Inhalator|
|EP0215559A1 *||Jul 31, 1986||Mar 25, 1987||Wilhelm Dr. Hurka||Inhaler|
|EP0388621A1 *||Feb 9, 1990||Sep 26, 1990||PHIDEA S.p.A.||Inhaler with regular complete emptying of the capsule|
|EP0506292A1 *||Mar 18, 1992||Sep 30, 1992||Rhone Poulenc Rorer Limited||Inhaler|
|EP0506293A1 *||Mar 18, 1992||Sep 30, 1992||Rhone Poulenc Rorer Limited||Inhaler|
|EP1245243A1 *||Mar 28, 2001||Oct 2, 2002||Ivo Pera||Pen-shaped inhaling device for dispersing powdered medicaments through the respiratory tract|
|EP1291032A2 *||Jul 25, 1994||Mar 12, 2003||Aventis Pharma Limited||Powder inhaler|
|EP1329236A1 *||Dec 3, 2002||Jul 23, 2003||PH&T S.p.A.||Device usable in the treatment of affections of the airways|
|EP1917992A2||Sep 15, 1995||May 7, 2008||Nektar Therapeutics||Apparatus and methods for dispersing dry powder medicaments|
|EP2630954A1||Mar 19, 2003||Aug 28, 2013||Civitas Therapeutics, Inc.||Pulmonary delivery for levodopa|
|EP2656867A2||Apr 4, 2007||Oct 30, 2013||Boehringer Ingelheim Pharma GmbH & Co. KG||Mouthpiece for an inhalator|
|EP2668970A1||Oct 25, 2007||Dec 4, 2013||Novartis AG||Powder dispersion apparatus|
|EP2679239A1||Jun 28, 2012||Jan 1, 2014||Apeptico Forschung und Entwicklung GmbH||Pharmaceutical compound for treating the pulmonary form of altitude sickness caused by oxygen deprivation and reduced air pressure|
|WO1992017232A1 *||Mar 18, 1992||Sep 29, 1992||Rhone Poulenc Rorer Ltd||Inhaler|
|WO1992017233A1 *||Mar 18, 1992||Sep 29, 1992||Rhone Poulenc Rorer Ltd||Inhaler|
|WO1994019041A1 *||Feb 28, 1994||Sep 1, 1994||Fisons Plc||Inhalation device|
|WO1999049918A1 *||Mar 30, 1999||Oct 7, 1999||Astra Ab||Inhalation device|
|WO2002007805A2 *||Jul 20, 2001||Jan 31, 2002||Cambridge Consultants||Inhalers|
|WO2003039636A1||Nov 1, 2002||May 15, 2003||Lilly Co Eli||Color-coded therapy unit|
|WO2003080163A1 *||Oct 10, 2002||Oct 2, 2003||Advanced Inhalation Res Inc||Puncturing means for use in an inhalation device|
|WO2004091707A2||Apr 9, 2004||Oct 28, 2004||Nektar Therapeutics||Aerosolization apparatus with capsule puncture alignment guide|
|WO2006051300A1 *||Nov 10, 2005||May 18, 2006||Cipla Ltd||Inhaler|
|WO2007011396A2||Oct 19, 2005||Jan 25, 2007||Harvard College||Particles for treatment of pulmonary infection|
|WO2007030162A2||May 18, 2006||Mar 15, 2007||Nektar Therapeutics||Valves, devices, and methods for endobronchial therapy|
|WO2007088188A1 *||Feb 1, 2007||Aug 9, 2007||Boehringer Ingelheim Pharma||Adapter for inhalation appliances for treatment of artificially ventilated patients|
|WO2007116002A1||Apr 4, 2007||Oct 18, 2007||Boehringer Ingelheim Int||Inhaler|
|WO2007118801A1||Apr 4, 2007||Oct 25, 2007||Boehringer Ingelheim Int||Inhaler|
|WO2008156381A1 *||May 29, 2008||Dec 24, 2008||Przed Produkcji||Inhaler for powder drug administration|
|WO2008156586A2 *||Jun 10, 2008||Dec 24, 2008||Alkermes Inc||Inhalation device for powdered substances|
|WO2009024254A2 *||Aug 1, 2008||Feb 26, 2009||Aha Kunststofftechnik Gmbh||Dry powder inhaler|
|WO2011020554A1 *||Aug 2, 2010||Feb 24, 2011||Gamptec Gmbh||Inhalation device and method for inhaling an active ingredient from a capsule|
|WO2011163518A1||Jun 23, 2011||Dec 29, 2011||Gilead Sciences, Inc.||Pyrazolo [1, 5 -a] pyrimidines as antiviral agents|
|WO2012012776A1||Jul 22, 2011||Jan 26, 2012||Gilead Sciences, Inc.||Methods and compounds for treating paramyxoviridae virus infections|
|WO2012030645A1||Aug 26, 2011||Mar 8, 2012||Pulmatrix, Inc.||Respirably dry powder comprising calcium lactate, sodium chloride and leucine|
|WO2012030664A1||Aug 26, 2011||Mar 8, 2012||Pulmatrix, Inc.||Dry powder formulations and methods for treating pulmonary diseases|
|WO2012037038A1||Sep 12, 2011||Mar 22, 2012||Gilead Sciences, Inc.||2' -fluoro substituted carba-nucleoside analogs for antiviral treatment|
|WO2012044736A1||Sep 29, 2011||Apr 5, 2012||Pulmatrix, Inc.||Monovalent metal cation dry powders for inhalation|
|WO2012050945A1||Sep 29, 2011||Apr 19, 2012||Pulmatrix, Inc.||Cationic dry powders|
|WO2012065201A1||Nov 15, 2011||May 24, 2012||Apeptico Forschung Und Entwicklung Gmbh||Composition comprising a peptide and an inhibitor of viral neuraminidase|
|WO2013130767A1||Feb 28, 2013||Sep 6, 2013||Pulmatrix, Inc.||Inhalable dry powders|
|WO2013158776A1||Apr 17, 2013||Oct 24, 2013||Gilead Sciences, Inc.||Compounds and methods for antiviral treatment|